Clinical Trial Update: Tolerability and Efficacy of Modified VCD Regimens in Previously Untreated Multiple Myeloma. [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update assesses tolerability and efficacy of modified VCD regimens in patients with previously untreated multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Decadron (Dexamethasone)
• Velcade (bortezomib)

Snippet

Sponsor: Yongping Zhai | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN